Avidity Biosciences, Inc. Profile Avatar - Palmy Investing

Avidity Biosciences, Inc.

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead produc…

Biotechnology
US, San Diego [HQ]

Lobbying Analysis

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
2024 3 $8,000,000 LD-2 : 10/18/24
2024 2 $8,000,000 LD-2 : 07/22/24
2024 1 $8,000,000 LD-2 : 04/22/24
2023 4 $8,000,000 LD-2 : 01/22/24
End of RNA's Analysis
CIK: 1599901 CUSIP: 05370A108 ISIN: US05370A1088 LEI: - UEI: -
Secondary Listings
RNA has no secondary listings inside our databases.